Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION COMPRISING AMNIOTIC FLUID STEM CELLS OR DERIVATIVES THEREOF AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/046329
Kind Code:
A1
Abstract:
Provided is a composition including stem cell is derived from amniotic fluid of an artiodactyl animal. Also provided relates to uses of the composition for skin rejuvenation, skin treatment, promoting hair growth, and preventing hair loss, including administering an effective amount of the composition to the subject in need thereof.

Inventors:
HWANG SHIAW-MIN (CN)
HUANG TZU-HAO (CN)
HUANG YU-SHAN (CN)
CHIEN FEN-REN (CN)
Application Number:
PCT/CN2023/115593
Publication Date:
March 07, 2024
Filing Date:
August 29, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
U NEURON BIOMEDICAL INC (CN)
International Classes:
C12N5/073; C12N5/0775
Domestic Patent References:
WO2020190885A12020-09-24
Other References:
EDOUARD BAULIER ET AL: "Amniotic Fluid-Derived Mesenchymal Stem Cells Prevent Fibrosis and Preserve Renal Function in a Preclinical Porcine Model of Kidney Transplantation", STEM CELLS TRANSLATIONAL MEDICINE, vol. 3, no. 7, 5 May 2014 (2014-05-05), US, pages 809 - 820, XP055578850, ISSN: 2157-6564, DOI: 10.5966/sctm.2013-0186
JIAHUAN CHEN ET AL: "Isolation and Characterization of Porcine Amniotic Fluid-Derived Multipotent Stem Cells", PLOS ONE, vol. 6, no. 5, 19 May 2011 (2011-05-19), pages e19964, XP055709008, DOI: 10.1371/journal.pone.0019964
"Remington: The Science and Practice of Pharmacy", 2012, THE PHARMACEUTICAL PRESS AND THE AMERICAN PHARMACEUTICAL ASSOCIATION
"Handbook of Pharmaceutical Additives", 2007, GOWER PUBLISHING COMPANY
"Pharmaceutical Preformulation and Formulation", 2009, CRC PRESS LLC: BOCA RATON
Attorney, Agent or Firm:
LUNG TIN INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF: